Literature DB >> 18164227

Reduction of acetate accumulation in Escherichia coli cultures for increased recombinant protein production.

Matthew S Wong1, Steven Wu, Thomas B Causey, George N Bennett, Ka-Yiu San.   

Abstract

The culture of Escherichia coli for the commercial production of recombinant proteins has increased significantly in recent years. The production of acetate as a byproduct retards cell growth, inhibits protein formation, and diverts carbon from biomass to protein product. Our approach to reducing acetate accumulation was to disable the phosphoenolpyruvate:sugar phosphotransferase system (PEP-PTS) by deleting the ptsHI operon in the wild-type E. coli strain GJT001. The mutation caused a severe reduction in growth rate and glucose uptake rate in glucose-supplemented M9 minimal medium, which confirmed the mutation, and eliminated acetate accumulation. The mutant strain (TC110) apparently metabolized glucose by a non-PTS mechanism that we are currently investigating, followed by phosphorylation by glucokinase. In complex medium such as 2xLB broth with 2% glucose, TC110 was able to grow quickly and still retained the phenotype of significantly reduced acetate accumulation (9.1+/-6.6 vs. 90.4+/-1.6mM in GJT001, P<0.05). The reduced acetate accumulation resulted in a significant improvement in final OD (23.5+/-0.7 in TC110 vs. 8.0+/-0.1 in GJT001, P<0.05). We tested the strains for the production of model recombinant proteins such as green fluorescent protein (GFP) and beta-galactosidase. TC110 had a 385-fold improvement in final volumetric productivity of GFP over GJT001 in shake flasks with 2xLB broth with 2% glucose. The distribution of GFP fluorescence in the cell population, as determined by flow cytometry, was much broader in GJT001 (coefficient of variation=466+/-35%) than in TC110 (coefficient of variation=55+/-1%). In corn steep liquor medium with 2% glucose, we observed a 28.5-fold improvement in final volumetric production of GFP in TC110 over GJT001. TC110 had a 7.5-fold improvement in final volumetric productivity of beta-galactosidase over GJT001 in 2xLB broth with 2% glucose medium. When tested in a batch bioreactor cultures with 2xLB broth with 2% glucose medium, the volumetric production of GFP by TC110 was 25-fold higher than that of GJT001. In summary, the ptsHI mutant of GJT001 resulted in reduced acetate accumulation, which led to significant improvements in recombinant protein production in batch bioreactors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18164227     DOI: 10.1016/j.ymben.2007.10.003

Source DB:  PubMed          Journal:  Metab Eng        ISSN: 1096-7176            Impact factor:   9.783


  15 in total

1.  Engineering Escherichia coli for high-level production of propionate.

Authors:  Lamees Akawi; Kajan Srirangan; Xuejia Liu; Murray Moo-Young; C Perry Chou
Journal:  J Ind Microbiol Biotechnol       Date:  2015-05-07       Impact factor: 3.346

Review 2.  Increasing recombinant protein production in Escherichia coli through metabolic and genetic engineering.

Authors:  Hendrik Waegeman; Wim Soetaert
Journal:  J Ind Microbiol Biotechnol       Date:  2011-09-08       Impact factor: 3.346

Review 3.  Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements.

Authors:  Chung-Jr Huang; Henry Lin; Xiaoming Yang
Journal:  J Ind Microbiol Biotechnol       Date:  2012-01-18       Impact factor: 3.346

4.  Improving acetate tolerance of Escherichia coli by rewiring its global regulator cAMP receptor protein (CRP).

Authors:  Huiqing Chong; Jianwei Yeow; Ivy Wang; Hao Song; Rongrong Jiang
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

Review 5.  Recent advances in engineering the central carbon metabolism of industrially important bacteria.

Authors:  Maria Papagianni
Journal:  Microb Cell Fact       Date:  2012-04-30       Impact factor: 5.328

6.  High-flux isobutanol production using engineered Escherichia coli: a bioreactor study with in situ product removal.

Authors:  Antonino Baez; Kwang-Myung Cho; James C Liao
Journal:  Appl Microbiol Biotechnol       Date:  2011-03-10       Impact factor: 4.813

7.  Metabolic engineering of the L-phenylalanine pathway in Escherichia coli for the production of S- or R-mandelic acid.

Authors:  Zhoutong Sun; Yuanyuan Ning; Lixia Liu; Yingmiao Liu; Bingbing Sun; Weihong Jiang; Chen Yang; Sheng Yang
Journal:  Microb Cell Fact       Date:  2011-09-13       Impact factor: 5.328

8.  Genome reduction boosts heterologous gene expression in Pseudomonas putida.

Authors:  Sarah Lieder; Pablo I Nikel; Víctor de Lorenzo; Ralf Takors
Journal:  Microb Cell Fact       Date:  2015-02-21       Impact factor: 5.328

9.  Strategies for Poly(3-hydroxybutyrate) Production Using a Cold-Shock Promoter in Escherichia coli.

Authors:  Thanawat Boontip; Rungaroon Waditee-Sirisattha; Kohsuke Honda; Suchada Chanprateep Napathorn
Journal:  Front Bioeng Biotechnol       Date:  2021-06-03

10.  Whole-cell bioreduction of aromatic alpha-keto esters using Candida tenuis xylose reductase and Candida boidinii formate dehydrogenase co-expressed in Escherichia coli.

Authors:  Regina Kratzer; Matej Pukl; Sigrid Egger; Bernd Nidetzky
Journal:  Microb Cell Fact       Date:  2008-12-10       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.